Sort by
Refine Your Search
-
Category
-
Country
-
Program
-
Field
-
, traditional risk prediction models like the Steno Type 1 Risk Engine fail to account for the immunological dysregulation inherent in T1D. Project Objective The PhD candidate will primarily focus on the clinical
-
to the iBV state-of-the-art technology platforms, including microscopy, cytometry, histology, bioinformatics, synthetic biology and animal facility infrastructures. He/she will be strongly supported by the iBV
-
research—from fundamental studies to clinical and public health research—INSERM supports 15,000 researchers, engineers, and administrative staff across laboratories throughout France. The institute's mission
-
(plan and carry out syntheses of the supramolecular polymers building blocks) • Protein expression in prokaryotic (bacteria) and eukaryotic (insect and human) cells. • Protein engineering, bioconjugation
-
14 Mar 2025 Job Information Organisation/Company INSERM Rhône Alpes Research Field Other Researcher Profile First Stage Researcher (R1) Positions Postdoc Positions Country France Application
-
& Augmented Surgery, Data Reuse and Multiparametric Evaluation – Inserm U1091, UniCA at IBV) and the surgical facilities of the University Institute for Locomotion and Sports of the University Hospital of Nice
-
7 Mar 2025 Job Information Organisation/Company INSERM Department Departement des Ressources Humaines Research Field Biological sciences » Biology Researcher Profile First Stage Researcher (R1
-
Institut des Sciences Chimiques de Rennes UMR 6226 CNRS - Université de Rennes 1 | Rennes, Bretagne | France | 3 months ago
15 Mar 2025 Job Information Organisation/Company Institut des Sciences Chimiques de Rennes UMR 6226 CNRS - Université de Rennes 1 Research Field Engineering Chemistry Researcher Profile Recognised
-
. These rhythmic stimulations play a key role in cognitive development by supporting language acquisition, communication, and social interactions. At Inserm U1105, we have shown that the brain of a premature newborn
-
from Gustave Roussy, Paris-Saclay University, CNRS, and INSERM. The AMMICa unit is at the forefront of cancer research, integrating 11 core facilities that collaborate seamlessly with Gustave Roussy’s